Radioactive stents are small expandable tubes that are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization. These stents are widely utilized in cancer treatment as they utilize high-energy gamma rays that destroy the cancer cells and prevent their proliferation.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Product development is the key strategy adopted by major players in the radioactive stents market players. The report provides a comprehensive analysis of the key players that operate in the global radioactive stents market. The key player of the market includes C.R. Bard, Inc., Cook Medical Inc., Medline Industries Ltd, Pnn Medical A/S, Allium Medical Solutions Ltd., APC Cardiovascular Ltd., Micro-Tech Pvt. Ltd., Changzhou Zhiye Co Ltd., Aetna Inc., and Abbott Laboratories.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/3758
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- The study provides an in-depth analysis of the global radioactive stents market, and the current trends and future estimations to elucidate the imminent investment pockets from 2016 to 2023.
- It presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product type assists in understanding the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/3758
Increase in incidence of coronary artery disease, emergence of innovative radioactive stents, and improved clinical outcomes due to stenting drive the market growth. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity, and improved insurance & reimbursement towards radioactive stents supplement the market growth. However, availability of alternative methods for coronary heart disease treatment and high cost of treatment-associated radioactive stents impede the market growth. Furthermore, the untapped emerging countries present lucrative opportunities for market expansion.
The global radioactive stents market is segmented based on product, application, stent size, and geography. Based on product, it is categorized into retrograde stents, antegrade stents, internal (double-j) stents, iodine-125 radioactive stent, and others. In terms of application, it is divided into lithotripsy, ureteroscopy, ureteroenoscopy, percutaneous nephrolithotomy, angiography, neointimal hyperplasia, esophageal cancer, biliary cancer, and others. Based on stent size, it is classified into 18 mm, 20 mm, 14 mm, and other stents. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060